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Objectives The objectives of this work were to establish the primary clinical determinants of pa-
tient radiation dose associated with percutaneous coronary interventional (PCI) and to identify op-
portunities for dose reduction.
Background Use of X-ray imaging and associated radiation dose is a necessary part of PCI. Potential
adverse consequences of radiation dose include skin radiation injury and predicted increase in life-
time cancer risk.
Methods Cumulative skin dose (CSD) (measured in gray [Gy] units) was selected as a measurement
of patient radiation burden. Several patient-, disease-, and treatment-related variables, including 15
performing physicians, were analyzed in a multiple linear regression statistical model with cumula-
tive skin dose CSD as the primary end point. The model results provide an estimate of the relative
CSD increase (decrease) attributable to each variable.
Results Percutaneous coronary interventions performed on 1,287 male and 540 female patients
were included. Median patient age was 68.6 years, median body mass index was 29.7 kg/m2, and
median weight was 88 kg. Median CSD was 1.64 Gy per procedure for male and 1.15 Gy for female
patients. Increasing body mass index, patient sex, lesion complexity, lesion location, and performing
physician were signiﬁcantly associated with CSD. Physicians who performed more procedures were
associated with lower CSD.
Conclusions Several primary determinants of patient radiation dose during PCI were identiﬁed.
Along with physician development of radiation-sparing methods and skills, pre-procedure dose plan-
ning is proposed to help minimize radiation dose for PCI. (J Am Coll Cardiol Intv 2011;4:336–43)
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337Understanding and reducing radiation dose in the coronary
interventional practice are important to minimize both the
potential for patient skin injury (a deterministic effect) and
the predicted cancer risk (a stochastic effect) for patients and
physician operators (1). In percutaneous interventional pro-
cedures, the tissue that receives the highest radiation dose is
the skin (2–7). Other organs also absorb X-ray energy and
contribute to patient effective dose. It is assumed that the
probability of radiation-induced cancer increases in direct
proportion to effective dose (8). Radiation dose reduction
for percutaneous coronary intervention (PCI) is particularly
important as procedures become more complex, potentially
resulting in longer procedures with expanded X-ray imaging
requirements.
See page 344
The radiation dose received by a patient during an
interventional procedure is highly variable and depends on
many technical and clinical factors. The technical factors
affecting radiation dose are well known and are generally a
function of the X-ray beam quality, X-ray geometry, X-ray
beam limitation devices, and fluoroscopic and acquisition
imaging dose rate settings (4). Clinical- and treatment-
related factors that influence patient radiation dose have
been described for diagnostic coronary angiography (CA)
(9–12) and/or PCI procedures (13–25). Specific investiga-
tion of the influence of individual performing physicians
and case volume on patient dose is underrepresented in
current literature. The purpose of this report is to examine
the primary determinants of radiation dose during PCI in a
diverse interventional practice that includes several physi-
cians and cardiology trainees.
Methods
PCI procedures. This work is based on retrospective analysis
f PCI procedures performed over a 14-month period
nding July 2009 and was approved by our Institutional
eview Board. All PCI procedures performed over this time
ere considered. Patients who had not provided medical
ecord research consent or whom also had concomitant
eripheral vascular intervention were excluded. Ours is a
eaching institution, and procedures were routinely per-
ormed by a staff interventional cardiologist and an inter-
entional fellow-in-training. Fellow involvement ranged
rom assisting to performing the procedure under the direct
upervision of a staff physician, though the level of fellow
nvolvement was not recorded and cannot be estimated from
his retrospective analysis. For all procedures, a staff physi-
ian was present at the procedure table and was responsible
or all aspects of the case, including administration of
adiation.The Mayo PCI Registry contains prospectively collected
ata on all PCIs performed and includes detailed baseline
linical, angiographic, and procedural characteristics. Ten
ercent of the registry records are audited quarterly by the
atabase supervisor for accuracy and quality control. For
ach procedure, radiation-monitoring data are recorded in a
eparate clinical information system. These data are re-
iewed monthly by our internal Cardiovascular Interven-
ional Labs Radiation Safety Committee.
Cumulative skin dose. Percutaneous coronary interventions
were performed using 1 of 7 X-ray systems. The “Type 1”
systems (n  3) have image intensifier detectors and charge-
coupled device cameras (Type 1, Integris, Philips Medical
Systems, Best, the Netherlands). All Type 1 systems have
biplane X-ray and are outfitted with an accessory radiation
monitoring system (PEMNET, Clinical Microsystems, Ar-
lington, Virginia) that reports
the X-ray exposure in air (in
roentgen [R] units) at the loca-
tion of the patient skin. The
“Type 2” systems (n  4) have
flat panel digital detectors (Ax-
iom Artis, Siemens Medical, Er-
langer, Germany). Three Type 2
systems have biplane X-ray and
all Type 2 systems report the air-
kerma (in gray [Gy] units) at the
interventional reference point (26).
All systems of a given type were
configured to result in nominally
equal exposure or air-kerma
rates.
The exposure in air values (R,
Type 1) and the air-kerma val-
ues (Gy, Type 2) are both fur-
ther referred to as total air-
kerma (Ka,r). The procedure
otal air-kerma values do not
nclude the contribution of X-ray backscatter from the
atient on skin dose. Therefore, Ka,r values were con-
erted to cumulative skin dose (CSD) (Gy) through
ultiplication by a measured Ka,r to skin dose conversion
actor (f) specific to each X-ray plane. The dose conver-
ion factors were measured using a stack of Solid Water
hantoms of thickness 15 cm to 40 cm and a 6-cm3
ionization chamber in conjunction with a calibrated
MDH 1015 electrometer (Radcal Corporation, Monro-
via, California). It is recognized that other works that
address radiation dose for cardiac catheterization proce-
dures have reported air-kerma area product (Gy cm2) or
a similar measurement (10,15–18,20,21,23,24,27–30). In
this study, the CSD is used to characterize the radiation
Abbreviations
and Acronyms
BMI  body mass index
CA  coronary angiography
CABG  coronary artery
bypass graft
CI  confidence interval
CSD  cumulative skin dose
CTO  chronic total
occlusion
LCX  left circumflex artery
LM  left main artery
PCI  percutaneous
coronary intervention
PVD  peripheral vascular
disease
STEMI  ST-segment
elevation myocardial
infarctiondose burden to the patient (25).
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338The X-ray systems are configured to use frame rates of
15 s1 for both fluoroscopy and cine acquisition imaging.
y default, the “normal” (vs. “low” or “high”) fluoroscopy
ose rate mode was selected. The maximum air-kerma rate
f normal fluoroscopy is controlled to be in the range 85 to
5 mGy/min. Although not specifically tracked, observation
ndicates that the fluoroscopic imaging mode was rarely
hanged from normal, 15 s1. The default cine acquisition
ode was used for all procedures. Physician operators
elected appropriate X-ray fields of view. For a 25-cm-thick
olid Water phantom, typical skin entrance dose rate values
or X-ray fluoroscopy and cine acquisition mode imaging are
2 mGy/min and 6.4 mGy/s, respectively. The default stent
or the majority of cases is frontal plane imaging, although
iplane imaging capability is available for nearly all X-ray
ystems.
Statistical methods. Many patient, disease, and procedural
escriptive variables were screened using a preliminary
nivariate analysis. The PCI procedures were assigned to 1
f 4 groups defined by CSD quartile. For each variable, the
nterquartile trend was examined using the Armitage test for
ategorical variables or with a contrast analysis in conjunc-
ion with analysis of variance for continuous variables.
ariables that were considered primary descriptors of the
atient, coronary disease, or procedure and that demon-
trated a significant trend in the quartile analysis (p  0.05)
ere included in a multiple linear regression model with
n[CSD] as the primary end point. The natural log of CSD
as modeled due to the right skewed distribution of CSD.
he multiple linear regression model provides a best-fit
arameter estimate (beta) for each variable. The relative
nfluence of each variable on cumulative skin dose is ebeta,
which will be referred to as the “relative CSD increase”
associated with each variable. Note that for beta 0, the
relative CSD increase is 1.0.
The model was formulated such that the intercept reflects
the expected ln[CSD] for a male patient with body mass
index (BMI) of 30 kg/m2 and no comorbidities undergoing
PCI on 1 simple lesion (Type A or B1) (31) within either
the left anterior descending or right coronary arteries.
Independent model variables included the number of com-
plex lesions (Type B2 or C, non–ST-segment elevation
myocardial infarction [STEMI], nonchronic total occlusion
[non-CTO]) treated per procedure, the number of CTO
(non-STEMI) lesions treated, and primary PCI for patients
presenting with STEMI. Both BMI and female sex were
included to account for the influence of patient size on
CSD. Patient history variables included diabetes, prior
coronary artery bypass graft (CABG), peripheral vascular
disease (PVD), and renal disease. Interventional locations of
left circumflex artery (LCX) and the left main artery (LM)
were included in the model. The type of X-ray system was
included as a variable to minimize bias that might arise from
differences in air-kerma rate. Use of the lateral X-ray planewas also included in the model. Finally, each of 15 staff
physicians who had primary responsibility for the proce-
dures were included as independent variables. Note that 1
“physician” was a group of 5 visiting physicians who
performed 4.4% of the procedures. Secondary analysis was
performed to investigate the relationship between the num-
ber of procedures performed per physician and physician-
specific influence on patient dose.
Results
Summary of patients, procedures, and lesions treated. Of
he 1,933 PCI procedures performed during the study
eriod, 1,827 were included in the study. Forty-one com-
ined PCI and vascular procedures were excluded as were 65
CIs performed on 58 patients who did not consent to have
heir records used for research. Procedures were performed
n 1,287 (70%) male patients and 540 (30%) female
atients. Considering all patients, the median age was 68.6
ears, BMI was 29.7 kg/m2, and weight was 88 kg. The
median age of female patients (71.7 years) was 4.2 years
greater than that of male patients (67.5 years) (Table 1).
Although BMI was independent of sex, male patients were
larger than female patients, with median weights being 91
kg and 75 kg, respectively. Diagnostic coronary angiography
was performed in conjunction with 86% of the procedures.
Stents were deployed in 93% of the patients and 85% of the
segments treated. Cardiovascular trainee physicians were
involved in 97% of the procedures. Additional patient,
procedure, and treated lesions summary statistics are pro-
vided in Tables 2 and 3.
CSD summary. Air-kerma to skin dose conversion factors (f)
were in the range 6.9  103 to 1.02  102 Gy/R for the
ype 1 systems and 8.1  104 to 9.8  104 (Gy/mGy)
or the Type 2 systems. For a given X-ray imaging plane, f
aried by6% in the phantom thickness range 15 to 40 cm.
A histogram of CSD values is provided in Figure 1 and
CSD is plotted against BMI in Figure 2. The median CSD
for male, female, and all patients was 1.64 Gy, 1.15 Gy, and
1.48 Gy, respectively (Table 4). There is a large variation in
CSD with the 95th percentile CSD 7.8 greater than the
5th percentile CSD.
Table 1. Statistical Summary of Patient Population
Median Mean 25th Percentile 75th Percentile
Age, men, yrs 67.5 66.6 58.1 75.4
Age, women, yrs 71.7 69.9 61.0 79.9
BMI,* men, kg/m2 29.7 30.6 26.9 33.2
BMI,* women, kg/m2 29.3 30.4 25.4 34.8
Weight, men, kg 91.0 94.3 82.0 104.0
Weight, women, kg 75.0 78.3 65.0 90.0
*Included as a variable in the multiple linear regression model.BMI body mass index.
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339All procedures included use of the frontal X-ray plane
and 13.7% also used the lateral plane. The lateral X-ray
plane accounted for a median of 40% (mean  38%, 25th
percentile  12%, 75th percentile  58%) of the CSD for
rocedures in which it was used and 7% of the CSD overall.
he lateral plane was used in 20% of procedures performed
n patients with renal insufficiency compared with 13% of
Table 2. Summary of Patients and Procedures
Men 1,287 (70)
Women 540 (30)
Diabetes 530 (29)
Hypertension 1,438 (83)
Hypercholesterolemia 1,502 (88)
Prior PCI 716 (39)
Prior CABG 388 (21)
Cancer 270 (15)
PVD 179 (10)
Renal disease 70 (4)
Multivessel disease 1,104 (63)
Congestive heart failure 246 (14)
Symptoms at presentation
STEMI 200 (11)
Stable angina 195 (11)
Unstable angina 915 (50)
Other 517 (28)
Procedural details
Radial access 156 (9)
Femoral access 1,668 (91)
Concomitant diagnostic CA 1,578 (86)
Segments treated per procedure, n 1.5 0.8
Stents per procedure 1.4 1.0
Fluoroscopy time, min 20.9 13.8
Values are n (%) or mean SD. Included as a variable in the multiple linear regression model.
CA  coronary angiography; CABG  coronary artery bypass graft; PCI  percutaneous
coronary intervention; STEMI ST-segment elevation myocardial infarction.
Table 3. Summary of Lesions Treated
Site of PCI
LAD 1,053 (38)
RCA 876 (32)
LCX* 598 (22)
LM* 82 (3)
Saphenous vein graft 158 (6)
Lesion type
A 41 (1.5)
B1 339 (12)
B2* 794 (29)
C* 1,236 (45)
Not speciﬁed 95 (33)
STEMI–type not applicable 264 (10)
Values are n (% of lesions). *Included as a variable in the multiple linear regression model.
Combined, Type B2 and C lesions represent the complex lesion variable.
LCX left circumflex artery; LM left main artery; RCA right coronary artery; other abbre-viations as in Table 2.he remaining patients (p  0.10). Fluoroscopic (vs. acqui-
ition) mode imaging accounted for 55% (55%, 43%, 66%)
f the CSD.
Model results. For the multiple linear regression model for
ln[CSD], inspection of plot residuals (normal quantile plot,
and vs. predicted values) did not reveal any violations of the
assumptions of model residuals being normally distributed
with a common variance. The model intercept, correspond-
ing to the expected dose for the reference male patient with
a BMI of 30 kg/m2, was 1.12 Gy (95% confidence intervals
[CI]: 1.05 Gy to 1.19 Gy). The relative CSD increase
presented in Figure 3 is the expected relative change in CSD
Figure 1. Distribution of the Number of Procedures as a Function of CSD
The distribution of the number of procedures for 1,287 men (blue) and
540 women (red) studied. The overall distribution is log-normal. CSD 
cumulative skin dose.
Figure 2. Semi-Log Plot Showing Relationship of CSD to BMI
Semi-log plot demonstrating increased cumulative skin dose (CSD) with
increasing body mass index (BMI).
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340when a variable is present during PCI (or when BMI is
increased by 5 kg/m2). The net influence of multiple
variables is multiplicative. The statistical model accounted
for 42% of the variability in the original ln[CSD] dataset
(r2  0.42).
Compared with the reference treatment of a single simple
esion (Type A or B1), a treatment of each complex (1.22;
5% CI: 1.18 to 1.25) or CTO (1.42; 95% CI: 1.35 to 1.49)
esion treated is associated with increased dose (Fig. 3).
imilarly, primary PCI in STEMI patients (1.09; 95% CI:
.01 to 1.19) is associated with a modest dose increase. We
ound that CSD increases with BMI and is presented in
igure 3 as a relative increase in dose (1.23; 95% CI: 1.20,
.25) for each BMI increment of 5 30 kg/m2. Regardless
of whether actual patient BMI is  or 30 kg/m2, the
absolute influence of BMI is 1.23(BMI  30)/5. In this man-
er, the expected relative dose increase (or decrease) attrib-
table to BMI can be estimated. Compared with the
eference male patient, significantly lower CSD was ob-
erved in female patients (0.72; 95% CI: 0.68 to 0.75). The
nfluence of diabetes (1.04; 95% CI: 0.99 to 1.10) and renal
isease (0.94; 95% CI: 0.83 to 1.07) on CSD was insignif-
Figure 3. Relative Effect of Nonphysician Variables on CSD
Error bars represent 95% conﬁdence interval. CABG  coronary artery bypass
Table 4. Statistical Summary of CSD*
Median Mean 25th Percentile 75th Percentile
Men 1.64 1.96 1.12 2.41
Women 1.15 1.39 0.77 1.83
All 1.48 1.79 0.99 2.24
*Cumulative skin dose (CSD) is measured in gray (Gy) units.artery; PCI  percutaneous coronary intervention; STEMI  ST-segment elevation mcant, whereas prior CABG (1.07; 95% CI: 1.01 to 1.14)
nd PVD (1.1; 95% CI: 1.02 to 1.19) are both predictive of
ncreased dose. Compared with other interventional sites,
CI of the LCX (1.14; 95% CI: 1.08 to 1.20) was associated
ith increased dose, whereas dose was unaffected by PCI of
he LM (1.02; 95% CI: 0.91 to 1.14). Use of the lateral
-ray plane (1.37; 95% CI: 1.28 to 1.47) was associated
ith a large dose increase and use of Type 1 X-ray systems
1.09; 95% CI: 1.03 to 1.15) was also associated with increased
ose.
The physician-specific influence on CSD was in the
ange 0.81 (95% CI: 0.76 to 0.87) to 1.25 (95% CI: 1.11 to
.41) as shown in Figure 4, except that the influence of the
roup of 5 visiting physicians (1.11; 95% CI: 0.00 to 1.23)
as excluded. There is a significant inverse correlation
etween the number of procedures performed and the
hysician-specific relative CSD increase. The slope of the
inear regression fit to the data of Figure 4 is 0.14 per 100
rocedures (r2  0.46, p  0.008).
Discussion
The findings of this work are specific to adult PCI proce-
dures and the major findings included: 1) lesion complexity,
PCI of LCX, and number of lesions treated was correlated
with CSD; 2) patient body habitus was correlated with
CSD; 3) previous CABG and PVD were correlated with
CSD, but radial access, diabetes, and renal insufficiency
were not; and 4) performing physician was significantly
CSD  cumulative skin dose; LCX  left circumﬂex artery; LM  left maingraft;
yocardial infarction.
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341correlated with CSD, with radiation dose reduction associ-
ated with higher volume operators CSD.
Lesion complexity and STEMI. Each non-STEMI procedure
had an average of 1.5 lesions treated. Most of these
procedures (73%) involved at least 1 complex lesion, each of
which has an associated relative CSD increase of 1.22.
Correlation between CSD and lesion type is consistent with
the intent of the modified AHA/ACC Task Force lesion
type score (31) and other works that reported on the
influences of lesion complexity on dose (18,20,21,25). Sim-
ilarly, that treatment of CTO is also associated with a
relative CSD increase of 1.42 is related to the increased
difficulty crossing, dilating, and then placing stents within
these lesions (13,32). Compared with the defined reference
patient for whom a single simple lesion was treated, primary
PCI for STEMI patients is associated with increased CSD
(1.09). This result should be interpreted in the context of
other patient procedures that typically involve treatment of
1 or more complex (1.22 per lesion) and/or CTO (1.42)
lesions. In this context, radiation dose associated with
primary PCI for STEMI is lower than that for complex PCI
(27).
Patient size. Using a BMI of 30 kg/m2 as the reference
alue, there is a substantial CSD increase (decrease) for
atients with BMI 30 kg/m2 (30 kg/m2), which can be
expressed as 1.23(BMI  30)/5. Compared with the reference
male patient, there is a substantial dose reduction for
females patients (0.72; 95% CI: 0.68 to 0.75) of equal BMI
(but who weigh an average of 16 kg less than male patients)
(21,23). Both of these influences are consistent with in-
creased (decreased) radiation dose rate implications of the
Figure 4. Influence of the Number of Procedures Performed on
Physician-Specific Relative CSD Increase
Error bars represent 95% CI; linear ﬁt slope  0.14 per 100 procedures.
Visiting physicians were excluded. CI  conﬁdence interval; other abbrevia-
tions as in Figure 3.automatic brightness control feature of the X-ray systemsfor larger (smaller) patients (4). Our experience is that the
relationship between patient dose and image quality can be
better managed if specific X-ray programs are used for
patients of varying size.
Patient history. In addition to accounting for lesion com-
plexity and patient size, the model demonstrates a radiation
dose increase of 1.07 for procedures performed on patients
who had prior CABG surgery (18) and 1.10 for patients
with PVD. These influences are modest, but are likely a result
of increased coronary disease severity, which tends to increase
the difficulty of the procedure. Although both diabetes and
renal disease were suggestive of association with dose in the
quartile analysis, neither of these variables demonstrated inde-
pendent statistical significance in the model analysis. In this
case, the apparent dose relationship to these variables observed
in the quartile analysis was more closely associated with other
independent variables in the model.
Lesion location. Compared with PCI performed in other
rteries, PCI performed in the LCX was associated with a
SD increase of 1.14. In this report, lesion location of LM
rtery was not independently associated with variation in
ose, whereas others have reported reduced dose for PCI in
he LM (21).
X-ray equipment-related inﬂuences. Use of the lateral X-ray
lane (1.37) in 14% of the procedures was associated with a
ubstantial increase in CSD. This result suggests that lateral
lane imaging, used either instead of or simultaneously with
he frontal plane, is overall less dose efficient than frontal
lane imaging. One reason for this is that lateral patient
hickness is greater than posterior-anterior patient thickness,
hereby resulting in increased skin dose rate for lateral plane
maging. Also, when imaging simultaneously with the frontal
nd lateral X-ray planes, it is unlikely that the clinical infor-
ation provided by the additional plane is proportional to the
dditional radiation dose delivered by that plane. Model results
ncluded that the Type 1 X-ray equipment, compared with the
ype 2 equipment, was associated with a CSD increase of
.09. This result is otherwise unremarkable.
Physician inﬂuence. A major finding of this work is that
patient dose is significantly influenced by the staff physician
with primary responsibility for the procedure (95% CI: 0.81
to 1.25) (Fig. 4). This result is independent of patient size,
lesion complexity, or other model variables. This finding is
consistent with differences in individual clinical practices,
experience, and attention to dose reduction methods (18,23)
(Table 5). Also, this current work demonstrates an inverse
correlation between the number of procedures performed by
individual physicians, over the 14-month study period, and
radiation dose (Fig. 4). This suggests that performing many
rather than few interventional procedures may help physi-
cians develop and maintain skills that ultimately lead to
reduced patient dose. However, physician-specific dose
variation may also be influenced by the degree to which
fellows either performed or assisted in the procedures. It has
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342been shown by others that increased operator experience
results in a reduction of radiation dose (33); therefore,
physicians who preferentially allow trainees to perform
rather than assist with procedures may be associated with
increased radiation dose. Though it is known that fellows
were involved in 97% of the procedures, the extent to which
fellows performed versus assisted procedures varied consid-
erably between cases and the degree to which the staff
physician actively supervised the administration of radiation
by the fellows is unknown. Therefore, this work offers no
specific insight into the influence that trainee fellows have
on patient radiation dose.
Summary of nonfactors. Other authors have reported radi-
ation dose association for radial versus femoral access (18)
whereas some others have reported no association (19). For
the current work, vascular access site did not demonstrate a
significant trend in the preliminary quartile analysis and,
therefore, was not included in the multiple linear regression
model. Although it is intuitive that PCI immediately
preceded by CA should use a greater radiation dose than
PCI alone (21), this trend was not indicated by the quartile
analysis. This finding is consistent with a previous report
from our laboratory (14). In this case, the anticipated effect
of CA (or absence of CA) is likely masked by the large
variability in CSD for PCI procedures (Fig. 2).
Dose trend over time. Considering all procedures, the me-
dian CSD (1.48 Gy) was 55% lower than that reported for
interventional procedures performed at our site in 1997 (3.2
Gy) (14). Compared with that study, the patients in this
study were larger with a mean weight of 89.6 kg versus 82.2
kg for the previous study. That patient skin dose has
decreased as patient size increased during the 12 years
between these studies indicates that substantial improve-
ments have been made to radiation dose management over
this time. This dose reduction over time can be attributed to
a combination of improved X-ray imaging technology
resulting in lower dose rate and improved interventional
methods and devices and radiation safety practices. Notable
among technical factors is that the standard frame rate for
both fluoroscopy and acquisition imaging has decreased
Table 5. Strategies for Reducing Patient Radiation Dose
Use best X-ray geometry (distance and angle) practices
Minimize use of steep caudal and cranial angles
Routinely monitor real-time air-kerma measurements during the procedure
Establish a clear treatment plan for complex and occluded lesions
Consider inﬂuences of new treatment technologies on radiation dose
Use lateral X-ray plane only when clinically necessary
Use lowest possible ﬂuoroscopy dose rate mode, including frame rate
Minimize the duration of X-ray beam use (ﬂuoroscopy and cine)
Develop and maintain interventional skillsfrom 30 s1 in 1997 to 15 s1.Methods for dose reduction. Based on the results of this
ork, there are several opportunities to reduce patient
adiation dose during PCI. Nearly one-half of the proce-
ures were performed on patients who are obese. Although
atient size cannot be modified at the time of the procedure,
t is known that steep X-ray tube angles result in increased
ffective patient thickness and radiation dose rate (14,21).
o minimize radiation dose (Table 5), it is particularly
mportant to minimize X-ray beam path length through the
atient by using the least possible X-ray projection angles.
hen treating complex or CTO lesions, radiation manage-
ent should be incorporated into pre-procedure planning.
lso for complex and CTO lesions, the potential for use of
dvanced technology such as improved interventional de-
ices (34), 3-dimensional vessel modeling (35–38), or mag-
etic catheter guidance (39) to reduce dose should be
urther investigated. This work demonstrates that use of the
ateral X-ray plane results in increased patient radiation
urden. To minimize radiation, the lateral X-ray plane
hould be used sparingly and only during those procedures
or which it is a clinical necessity. Finally, this work
emonstrates that individual physician operators can have a
ubstantial influence on patient dose. All staff and trainee
hysicians should be well trained and skilled at their craft
nd must uniformly adopt established technical and behav-
oral methods to minimize radiation dose (4).
onclusions
Several primary determinants of radiation burden to pa-
tients undergoing PCI were identified. Complexity, num-
ber, and location of lesions were associated with radiation
skin dose. Skin dose correlated with patient size, increasing
significantly with increasing BMI and decreasing for female
versus male patients. Notably, this work demonstrates that
patient radiation dose varies substantially among physicians
and that there is an inverse correlation of patient dose with
operator volume.
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